Literature DB >> 18393945

Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety.

W G Murphy1, M Foley, C Doherty, G Tierney, A Kinsella, A Salami, E Cadden, P Coakley.   

Abstract

BACKGROUND AND OBJECTIVES: We introduced 100% screening of platelets for bacterial contamination in 2005 to reduce the risk of clinical sepsis from platelet transfusion. We test all outdating units again at expiry to assess the sensitivity of the initial test.
MATERIALS AND METHODS: We test all platelet concentrates prior to release for clinical use using a large volume automated culture technique on the day after manufacture. All units that expire unused are retested. Platelets still in stock on day 4 of storage may have a repeat culture performed, and are returned to stock with two extra days of shelf life.
RESULTS: Of 43,230 platelet units screened, 35 (0.08%) were positive; of 8282 expired unused, 18 (0.22%) were positive; and of 3310 day-4 retests, four (0.12%) were positive. Overall sensitivity of the initial screening test was 29.2% (95% confidence interval 19.4 to 39.1%). Thirteen of the 35 positive screening tests would have been expected to grow in both aerobic and anaerobic bottles; eight grew in aerobic culture only and five grew in anaerobic culture only, indicating that the likely number of bacteria in the contaminated platelet units at the time of sampling was less than 60 colony-forming unit per platelet unit.
CONCLUSIONS: Screening platelet concentrates for bacterial contamination using the most sensitive method available has a sensitivity of less than 40% because of the low numbers of bacteria in the initial contamination. Effective resolution of this problem will require a pathogen-inactivation technique.

Mesh:

Year:  2008        PMID: 18393945     DOI: 10.1111/j.1423-0410.2008.01051.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  21 in total

1.  Effect of Safety Measures on Bacterial Contamination Rates of Blood Components in Germany.

Authors:  Gabriele Walther-Wenke; Walter Däubener; Margarethe Heiden; Jochen Hoch; Britt Hornei; Peter Volkers; Carl Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2011-07-11       Impact factor: 3.747

2.  10 Years Experience with Bacterial Screening of Platelet Concentrates in the Netherlands.

Authors:  Dirk de Korte
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

3.  Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for Bacteria.

Authors:  Thomas H Müller; Thomas Montag; Axel W Seltsam
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

Review 4.  Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components.

Authors:  Giancarlo Maria Liumbruno; Liviana Catalano; Vanessa Piccinini; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

5.  Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions.

Authors:  Seema Kacker; Evan M Bloch; Paul M Ness; Eric A Gehrie; Christi E Marshall; Parvez M Lokhandwala; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-01-08       Impact factor: 3.157

6.  UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.

Authors:  Axel Seltsam; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2011-01-22       Impact factor: 3.747

Review 7.  Microbiological Screening of Platelet Concentrates in Europe.

Authors:  Marcel Prax; Isabelle Bekeredjian-Ding; Oleg Krut
Journal:  Transfus Med Hemother       Date:  2019-03-20       Impact factor: 3.747

Review 8.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

9.  Antibodies to Leptospira among blood donors in higher-risk areas of Australia: possible implications for transfusion safety.

Authors:  Helen Faddy; Clive Seed; Colleen Lau; Vanessa Racloz; Robert Flower; Lee Smythe; Mary-Anne Burns; Michael Dohnt; Scott Craig; Robert Harley; Philip Weinstein
Journal:  Blood Transfus       Date:  2014-06-19       Impact factor: 3.443

10.  Light-based methods for whole blood bacterial inactivation enabled by a recirculating flow system.

Authors:  Gwangseong Kim; Mahsa Karbaschi; Marcus Cooke; Angelo Gaitas
Journal:  Photochem Photobiol       Date:  2018-03-31       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.